GRA 2012 > Programs/Initiatives

	Search

Programs/Initiatives

Stories

Newsroom

Publications & Resources

Georgia Cancer Coalition

GRA helps fuel the launch of companies

Since 2002, GRA VentureLab has evaluated the commercial potential of more than 600 inventions or discoveries at universities. The most promising of these were awarded VentureLab grants to help fund the technology research necessary to further develop the invention or discovery. This process has led to the formation of more than 120 early-stage companies that employ nearly 600 people and have attracted $460 million in private equity investment. More about VentureLab >

GRA also works with established Georgia companies through the Georgia Department of Economic Development and the Georgia Centers of Innovation in aerospace, logistics, life sciences, energy, agriculture and advanced manufacturing. The COIs help find technology solutions to industry challenges, in part by connecting companies to leading-edge research at Georgia's universities.

The following table offers more information about some of the companies that GRA has supported.


ArunA Biomedical	FOCUS: Research reagents derived from stem cells. • UNIVERSITY ORIGIN: University of Georgia.
Axion Biosystems	FOCUS: Neural interfacing technologies for research applications • UNIVERSITY ORIGIN: University of Georgia
Body Surface Translations	FOCUS: Stereoscopic imaging technology for agribusiness • UNIVERSITY ORIGIN: University of Georgia
CardioMEMS	FOCUS: MEMS medical devices to manage chronic cardiovascular disease. • UNIVERSITY ORIGIN: Georgia Tech
Damballa	FOCUS: Detection and mitigation of network computer attacks • UNIVERSITY ORIGIN: Georgia Tech
Digital Vision	FOCUS: Instrumentation for optimizing vision measurement • UNIVERSITY ORIGIN: Georgia Tech
GeoVax	FOCUS: Vaccine development for HIV/AIDS • UNIVERSITY ORIGIN: Emory University
Lancope	FOCUS: Computer network security • UNIVERSITY ORIGIN: Georgia Tech
MedShape Solutions	FOCUS: Shape memory devices for orthopedic applications • UNIVERSITY ORIGIN: Georgia Tech
NeurOp	FOCUS: Small molecule drugs for central nervous system applications • UNIVERSITY ORIGIN: Emory University
REACH Health	FOCUS: Web-based diagnosis of stroke and other medical conditions • UNIVERSITY ORIGIN: Georgia Health Sciences University (formerly Medical College of Georgia)
Sentrinsic	FOCUS: Sensing and control technologies to add intelligence to industrial equipment • UNIVERSITY ORIGIN: Georgia Tech
Suniva	FOCUS: High-efficiency silicon photovoltaic cells • UNIVERSITY ORIGIN: Georgia Tech
Trellis	FOCUS: Therapeutic antibodies for infectious diseased • UNIVERSITY BASE: University of Georgia
Urjanet	FOCUS: Management of energy production and consumption • UNIVERSITY ORIGIN: Georgia Tech
Velocity Medical Solutions	FOCUS: Software for cancer therapy management and analysis • UNIVERSITY ORIGIN: Emory University
Whisper Communications	FOCUS: Wireless security and privacy technology • UNIVERSITY ORIGIN: Georgia Tech
Zenda Technologies	FOCUS: Testing for mild cognitive impairment related to injury or early Alzheimer's disease • UNIVERSITY ORIGIN: Emory University and Georgia Tech


Dr. John Copeland – the first GRA Eminent Scholar – detected a major "denial-of-service" attack targeting Apple computers in late 1999. The discovery led to his development of software that now protects computer networks at the State of Georgia and a number of major corporations.